AIC
AVNS

Archer Investment Corporation’s Avanos Medical AVNS Stock Holding History

Archer Investment Corporation’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$578 – 1163
2025
Q3 		$578 Hold
50
– – ﹤0.01% 1100
2025
Q2 		$612 Hold
50
– – ﹤0.01% 1066
2025
Q1 		$717 Hold
50
– – ﹤0.01% 1024
2024
Q4 		$796 Hold
50
– – ﹤0.01% 1016
2024
Q3 		$1.2K Hold
50
– – ﹤0.01% 960
2024
Q2 		$996 Hold
50
– – ﹤0.01% 964
2024
Q1 		$996 Hold
50
– – ﹤0.01% 952
2023
Q4 		$1.12K Hold
50
– – ﹤0.01% 949
2023
Q3 		$1.01K Hold
50
– – ﹤0.01% 925
2023
Q2 		$1.28K Hold
50
– – ﹤0.01% 892
2023
Q1 		$1.49K Hold
50
– – ﹤0.01% 755
2022
Q4 		$1.35K Hold
50
– – ﹤0.01% 735
2022
Q3 		$1.09K Hold
50
– – ﹤0.01% 723
2022
Q2 		$1.37K Hold
50
– – ﹤0.01% 711
2022
Q1 		$1.68K Hold
50
– – ﹤0.01% 711
2021
Q4 		$1.73K Hold
50
– – ﹤0.01% 695
2021
Q3 		$1.56K Hold
50
– – ﹤0.01% 660
2021
Q2 		$1.82K Hold
50
– – ﹤0.01% 536
2021
Q1 		$2.19K Hold
50
– – ﹤0.01% 672
2020
Q4 		$2.29K Hold
50
– – ﹤0.01% 630
2020
Q3 		$1.66K Hold
50
– – ﹤0.01% 582
2020
Q2 		$1.47K Hold
50
– – ﹤0.01% 586
2020
Q1 		$1K Sell
50
-261
-84% -$7.79K ﹤0.01% 552
2019
Q4 		$10K Hold
311
– – 0.01% 448
2019
Q3 		$12K Hold
311
– – 0.01% 321
2019
Q2 		$14K Hold
311
– – 0.01% 311
2019
Q1 		$14K Hold
311
– – 0.01% 310
2018
Q4 		$14K Buy
+311
New +$16.3K 0.01% 299

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Archer Investment Corporation's AVNS Position: Q4 2025 in Review

Archer Investment Corporation sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 50 shares — an estimated $578 sold.

Archer Investment Corporation first reported a position in AVNS in Q4 2018 and held it in 28 quarters. The position peaked at $14K in Q2 2019. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Archer Investment Corporation reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Archer Investment Corporation sold 50 Avanos Medical shares in Q4 2025, an estimated $578.
  • Archer Investment Corporation first reported a position in Avanos Medical in Q4 2018 and held it in 28 quarters.
  • Archer Investment Corporation's Avanos Medical position peaked at $14K in Q2 2019.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Archer Investment Corporation's 13F filing for Q4 2025, filed 30 Jan 2026.